Founded in 2018, Answer Genomics operates in Health Tech industry. Initially focused on personal genomics, the company has evolved to integrate customized wellness recommendations through data analyti...
Funding stage:
Seed
Last funding:
04/10/2023
Total funding:
$500.00K+
Revenue:
Investors
Employee count:
4
Last 90d
4
Last 90d
Answer Genomics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders91
Latest Filing Date09 Aug 2023- Funding Events6
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Answer Genomics
As of 10 August 2023, Answer Genomics's equity is held by 90 shareholders, with the top three being Rahul Ranganathan, Andiyakkal Rajendran Balamurali, and FirstPort Capital.
Rahul Ranganathan holds the largest stake in Answer Genomics at 49.2% as of 10 August 2023.
As of 10 August 2023, founders collectively hold 56.3% equity in Answer Genomics.
As of 10 August 2023, investors collectively hold 27.1% equity in Answer Genomics.
Answer Genomics's ESOP pool stands at 9.2% of total equity as of 10 August 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links